Web: | mayocliniclabs.com |
---|---|
Email: | mcl@mayo.edu |
Telephone: | 800-533-1710 |
International: | +1 855-379-3115 |
Values are valid only on day of printing. |
Establishing a molecular diagnosis for patients with acute porphyria
Identifying variants within genes known to be associated with acute porphyria, allowing for predictive testing of at-risk family members
This test utilizes next-generation sequencing to detect single nucleotide and copy number variants in 4 genes associated with acute porphyria: ALAD, CPOX, HMBS, PPOX. See Targeted Genes and Methodology Details for Acute Porphyria Gene Panel in Special Instructions and Method Description for additional details.
Identification of a pathogenic variant may assist with diagnosis, prognosis, clinical management, familial screening, and genetic counseling for acute porphyria.
Additional first tier testing may be considered/recommended. For more information see Testing Algorithm section.
The following algorithms are available in Special Instructions:
Custom Sequence Capture and Targeted Next-Generation Sequencing followed by Polymerase Chain Reaction (PCR) and Sanger Sequencing.